COST-EFFECTIVENESS OF SWITCHING STRATEGIES FROM A 7-VALENT TO A 13-VALENT PNEUMOCOCCAL CONJUGATE VACCINE

被引:1
|
作者
Claes, C. [1 ]
Mittendorf, T. [1 ]
Kuchenbecker, U. [2 ]
Rose, M. [3 ]
Reinert, R. R. [4 ]
机构
[1] Leibniz Univ Hannover, Hannover, Germany
[2] Wyeth Pharma, Munster, Germany
[3] Goethe Univ Frankfurt, Frankfurt, Germany
[4] Wyeth Vaccines Res, Paris, France
关键词
D O I
10.1016/S1098-3015(10)75100-7
中图分类号
F [经济];
学科分类号
02 ;
摘要
引用
收藏
页码:A425 / A425
页数:1
相关论文
共 50 条
  • [1] COST-EFFECTIVENESS OF SWITCHING FROM THE 10-VALENT TO THE 13-VALENT PNEUMOCOCCAL CONJUGATE VACCINE IN SWEDEN
    Wasserman, M.
    Dorange, A. C.
    Palmborg, A.
    McDade, C.
    Wilson, M.
    Horn, E.
    [J]. VALUE IN HEALTH, 2022, 25 (01) : S110 - S110
  • [2] COST-EFFECTIVENESS OF 13-VALENT AND 10-VALENT PNEUMOCOCCAL CONJUGATE VACCINATION RELATIVE TO 7-VALENT PNEUMOCOCCAL CONJUGATE VACCINATION IN CANADA
    Whillans, F.
    Kwan, H.
    Strutton, D. R.
    Earnshaw, S. R.
    Farkouh, R.
    [J]. VALUE IN HEALTH, 2009, 12 (07) : A425 - A425
  • [3] Cost-effectiveness and Health Benefits of Pediatric 23-valent Pneumococcal Polysaccharide Vaccine, 7-valent Pneumococcal Conjugate Vaccine and Forecasting 13-valent Pneumococcal Conjugate Vaccine in China
    Mo, Xiuting
    Tobe, Ruoyan Gai
    Liu, Xiaoyan
    Mori, Rintaro
    [J]. PEDIATRIC INFECTIOUS DISEASE JOURNAL, 2016, 35 (11) : E353 - E361
  • [4] Compared effectiveness of the 7-valent pneumococcal conjugate vaccine in children with the 13-valent vaccine in adults
    Gaillat, J.
    [J]. MEDECINE ET MALADIES INFECTIEUSES, 2013, 43 (06): : 215 - 221
  • [5] Cost-effectiveness of 13-valent pneumococcal conjugate vaccine in Switzerland
    Blank, Patricia R.
    Szucs, Thomas D.
    [J]. VACCINE, 2012, 30 (28) : 4267 - 4275
  • [6] Vaccine effectiveness of the 7-valent and 13-valent pneumococcal conjugate vaccines in Canada: An IMPACT study
    Vojicic, Jelena
    Grajales, Ana Gabriela
    Cane, Alejandro
    [J]. VACCINE, 2023, 41 (27) : 3949 - 3950
  • [7] Vaccine effectiveness of the 7-valent and 13-valent pneumococcal conjugate vaccines in Canada: An IMPACT study
    Ricketson, Leah J.
    Bettinger, Julie A.
    Sadarangani, Manish
    Halperin, Scott A.
    Kellner, James D.
    [J]. VACCINE, 2022, 40 (19) : 2733 - 2740
  • [8] Cost-effectiveness of conjugate pneumococcal vaccination in Singapore: Comparing estimates for 7-valent, 10-valent, and 13-valent vaccines
    Tyo, Karen Richards
    Rosen, Melissa M.
    Zeng, Wu
    Yap, Mabel
    Pwee, Keng Ho
    Ang, Li Wei
    Shepard, Donald S.
    [J]. VACCINE, 2011, 29 (38) : 6686 - 6694
  • [9] THE COST-EFFECTIVENESS OF THE 13-VALENT PNEUMOCOCCAL CONJUGATE VACCINE IN CHINESE CITIES
    Furnback, W.
    Wang, B. C. M.
    Zhu, S.
    Dong, P.
    [J]. VALUE IN HEALTH, 2020, 23 : S170 - S170
  • [10] Cost-effectiveness of the 13-valent Pneumococcal Conjugate Vaccine in Children in Portugal
    Gouveia, Miguel
    Fiorentino, Francesca
    Jesus, Goncalo
    Costa, Joao
    Borges, Margarida
    [J]. PEDIATRIC INFECTIOUS DISEASE JOURNAL, 2017, 36 (08) : 782 - 787